Zimbabwe has rejected a significant American health deal worth $367m (£272m) over five years because of the United States' demand for confidential information.
This rejection was revealed after a internal memorandum from December was disclosed, indicating that Head of State Emmerson Mnangagwa felt the deal was "skewed".
An official spokesman later explained that the United States was requesting genetic material for research and profit while was not willing to share the resulting advantages from future medical innovations.
"We will now turn to the difficult and regrettable process of scaling back our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy said the United States had furnished more than $1.9bn as health assistance to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has called for further talks to find a agreement acceptable to both sides so the nation's critical HIV treatment initiative can be sustained.
Wider Background
This rejection follows a comparable case in Kenya, where a court blocked a similar health funding agreement following concerns were filed about the safety of Kenyans' health data.
After returning to the presidency recently, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.
The agency had overseen aid for the American government, but Trump stated its spending was "inefficient" and his administration was pursuing direct bilateral deals to enhance openness and accountability.
Based on statements, Sixteen nations in Africa have to date signed similar agreements, constituting over $18.3bn in committed funds.
Details of the Rejected Deal
This assistance for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this partnership would have delivered significant advantages for Zimbabwean communities, particularly the 1.2 million currently on antiretroviral therapy via American-funded initiatives," Tremont commented.
However, official spokesman Nick Mangwana maintained the arrangement was "asymmetrical".
"Our nation was requested to share its genetic material and health information for a long time, without any equivalent guarantee of benefiting from any medical innovations – such as new medicines or tests – that might result from that shared data," Mangwana explained.
"In essence, our nation would supply the raw materials for medical research without any certainty that the final treatments would be accessible to our people should a future pandemic arise."
National Interest and International Frameworks
Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral deals were undermining structures previously established via the international health agency.
Mangwana cited its Pathogen Access and Benefit Sharing system created to manage potential pandemics.
"This system is designed to guarantee that when a country contributes its data, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the funds to create them."
These objections regarding the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We welcome ongoing discussions with our US partners on how future co-operation might be designed in a way that honours the sovereignty and dignity of both nations."
Health Experts Response
A leading public health body said it acknowledged the government's concerns, but urged that talks need to persist considering a large portion of the nation's Aids initiatives were funded by foreign aid.
"In cases where specific concerns exist, such as those relating to data governance or implementation frameworks, these can often be addressed via technical clarification and mutually agreed protections," the group said.
The situation highlights the complex tensions between receiving crucial foreign assistance and safeguarding local interests in an increasingly interconnected world.